Skip to main content
. 2020 Nov 27;12(11):e11732. doi: 10.7759/cureus.11732

Table 2. The relation between clinical and biochemical HA variables with the severity of FPHL in 362 women.

a For 307 women only, representing 84.81% of women with FPHL. Abbreviations: BMI, body mass index; BT, bioavailable testosterone; DHEA-S, dehydroepiandrosterone sulfate; FPHL, female pattern hair loss; FT, free testosterone; HOMA-IR, homeostatic model assessment-insulin resistance; mFG, modified Ferriman Gallwey; SHBG, sex hormone-binding globulins; TT, total testosterone.

Parameters of hyperandrogenism FPHL severity according to Sinclair’s score p
Mild  (n=287) Moderate (n=67) Severe (n=8)
Clinical hyperandrogenism        
Hirsutism severity according to mFG n (%) Mild, mFG score ≤15 (n=134) 111 (38.7) 20 (29.9) 3 (37.5) <0.001
Moderate, mFG score between 16 - 25 (n=130) 93 (32.4) 35 (52.2) 2 (25.0)
Severe, mFG score > 25 (n=27) 18 (6.3) 6 (9.0) 3 (37.5)
No hirsutism, mFG score ≤8 (n=71) 65 (22.6) 6 (9.0) 0 (0)
Presentation with acne n (%) Yes (n=57) 39 (13.6) 15 (22.4) 3 (37.5) 0.048
No (n=305) 248 (86.4) 52 (77.6) 5 (62.5)
Biochemical hyperandrogenism        
TT High (n=108) 89 (31.0) 16 (23.9) 3 (37.5) 0.461
Normal (n=254) 198 (69.0 51 (76.1) 5 (62.5)
Calculated FT High (n=188) 154 (53.7) 28 (41.8) 6 (75.0) 0.09
Normal (n=174) 133 (46.3) 39 (58.2) 2 (25.0)
Calculated BT High (n=284) 227 (79.1) 50 (74.6) 7 (87.5) 0.595
Normal (n=78) 60 (20.9) 17 (25.4) 1 (12.5)
DHEA-S b High (n=74) 55 (19.2) 17 (25.4) 2 (25) 0.703
Normal (n=233) 184 (64.1) 44 (65.7) 5 (62.5)
Other associated variables        
SHBG Low (n=61) 47 (16.4) 14 (20.9) 0 (0) 0.600
Normal (n=294) 234 (81.5) 52 (77.6) 8 (100)
High (n=7) 6 (2.1) 1 (1.5) 0 (0)
HOMA-IR High (n=228) 173 (60.3) 48 (71.6) 7 (87.5) 0.077
Normal (n=134) 114 (39.7) 19 (28.4) 1 (12.5)
BMI High (n=283) 223 (77.7) 53 (79.1) 7 (87.5) 0.631
Normal (n=79) 64 (22.3) 14 (20.9) 1 (12.5)
Duration of FPHL years (mean ± SD) 3.33 ± 2.54 4.11 ± 3.28 2.25 ± 1.83 0.45